ASTI — Aquarius Surgical Technologies Cashflow Statement
0.000.00%
- CA$0.28m
- CA$6.84m
- CA$0.09m
Annual cashflow statement for Aquarius Surgical Technologies, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2021 March 31st | C2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -1.81 | -0.859 | -0.723 | -0.758 | -1.17 |
Depreciation | |||||
Non-Cash Items | 0.987 | 0.192 | 0.107 | 0.289 | 0.649 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.278 | 0.504 | 0.685 | 0.186 | 0.105 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -0.409 | -0.112 | 0.077 | -0.253 | -0.383 |
Capital Expenditures | -0.1 | -0.005 | 0 | -0.004 | 0 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0 | — | — | — | -1.8 |
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -0.1 | -0.005 | 0 | -0.004 | -1.8 |
Financing Cash Flow Items | 0 | -0.024 | -0.024 | -0.024 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.55 | 0.13 | -0.113 | 0.242 | 2.08 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.041 | 0.012 | -0.036 | -0.015 | -0.1 |